These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3761073)

  • 21. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
    Daly A; Evans S; Chahal S; Santra S; MacDonald A
    J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discrimination of heterozygotes for phenylketonuria, persistent hyperphenylalaninemia and controls by phenylalanine loading.
    Blitzer MG; Bailey-Wilson JE; Shapira E
    Clin Chim Acta; 1986 Dec; 161(3):347-52. PubMed ID: 3802540
    [No Abstract]   [Full Text] [Related]  

  • 23. A simplified PKU gene carrier detection test using fasting blood.
    Tenenholz B; Wenger SL; Breck J; Steele MW
    Clin Genet; 1983 Feb; 23(2):115-9. PubMed ID: 6839523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newborn phenylalanine/tyrosine metabolism. Implications for screening for phenylketonuria.
    Schneider AJ
    Am J Dis Child; 1983 May; 137(5):427-32. PubMed ID: 6846269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular concentrations of phenylalanine, tyrosine and alpha-aminobutyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria (PKU) compared with 26 normals.
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    Hum Genet; 1980; 54(2):213-6. PubMed ID: 7390492
    [No Abstract]   [Full Text] [Related]  

  • 26. Linkage analysis using heterozygote detection in phenylketonuria.
    Paul TD; Brandt IK; Elsas LJ; Jackson CE; Nance CS; Nance WE
    Clin Genet; 1979 Oct; 16(4):217-32. PubMed ID: 519892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased serum ubiquinone-10 concentrations in phenylketonuria.
    Artuch R; Vilaseca MA; Moreno J; Lambruschini N; Cambra FJ; Campistol J
    Am J Clin Nutr; 1999 Nov; 70(5):892-5. PubMed ID: 10539751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
    Sharman R; Sullivan K; Young R; McGill J
    Dev Neuropsychol; 2010; 35(1):57-65. PubMed ID: 20390592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved identification of heterozygotes for phenylketonuria using blood neopterin and biopterin.
    Alós T; Bel Y; Cabello ML; Catalá JL; Dalmau J; Ferré J; García AM; Ruiz-Vázquez P
    J Inherit Metab Dis; 1993; 16(2):457-64. PubMed ID: 8412006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of phenylketonuria carriers.
    Kelly S; Rose F
    Public Health Rep (1896); 1969 Feb; 84(2):144-8. PubMed ID: 4980161
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum prolactin as a biomarker for the study of intracerebral dopamine effect in adult patients with phenylketonuria: a cross-sectional monocentric study.
    Juhász E; Kiss E; Simonova E; Patócs A; Reismann P
    Eur J Med Res; 2016 May; 21(1):22. PubMed ID: 27169416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of blood phenylalanine concentration on Kuvan™ response in phenylketonuria.
    Elsas LJ; Greto J; Wierenga A
    Mol Genet Metab; 2011 Apr; 102(4):407-12. PubMed ID: 21216643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dietary aspartame on plasma concentrations of phenylalanine and tyrosine in normal and homozygous phenylketonuric patients.
    Mackey SA; Berlin CM
    Clin Pediatr (Phila); 1992 Jul; 31(7):394-9. PubMed ID: 1617863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The factor analytic, logarithmic and optimum solutions in separating heterozygous carriers and normal control subjects in phenylketonuria.
    Kääriäinen R
    Hereditas; 1973; 75(2):241-9. PubMed ID: 4782045
    [No Abstract]   [Full Text] [Related]  

  • 36. Heterozygote detection in phenylketonuria. Measurement of discriminatory ability and interpretation of the phenylalanine loading test by determination of the heterozygote likelihood ratio.
    Westwood A; Raine DN
    J Med Genet; 1975 Dec; 12(4):327-33. PubMed ID: 1219115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous measurement of phenylalanine and tyrosine in phenylketonuric plasma and dried blood by high-performance liquid chromatography.
    Dale Y; Mackey V; Mushi R; Nyanda A; Maleque M; Ike J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(1):1-8. PubMed ID: 12668065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gas chromatography-mass spectrometry method for determination of phenylalanine and tyrosine in neonatal blood spots.
    Deng C; Deng Y; Wang B; Yang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(2):407-13. PubMed ID: 12401368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intracellular concentration of phenylalanine, tyrosine and alpha-amino butyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria (PKU) compared with 26 normals (author's transl)].
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    Klin Padiatr; 1980 Nov; 192(6):608-12. PubMed ID: 7194402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Method of detection of heterozygotic carrier state in phenylketonuria].
    Baikov AD; Sitnichenko EI
    Lab Delo; 1973; 5():293-5. PubMed ID: 4129158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.